流通市值:483.98亿 | 总市值:483.98亿 | ||
流通股本:26.93亿 | 总股本:26.93亿 |
报告期 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
公司类型 | 通用 | 通用 | 通用 | 通用 |
一、经营活动产生的现金流量: | ||||
销售商品、提供劳务收到的现金 | 79,638,836,340.7 | 56,019,778,650.08 | 37,397,785,481.14 | 18,495,957,827.41 |
客户存款和同业存放款项净增加额 | -615,318,073.76 | -248,859,071.47 | 137,040,521.14 | -1,100,195,833.24 |
收取利息、手续费及佣金的现金 | 201,942,813.18 | 158,969,210.61 | 107,144,967.85 | 49,274,118.03 |
回购业务资金净增加额 | 31,918,062.02 | -1,088,131,069.77 | -82,125,890.87 | 30,498,461.86 |
收到的税费返还 | 22,655,465.09 | 93,528,516.07 | 52,632,456.83 | 25,876,708.1 |
收到其他与经营活动有关的现金 | 478,978,089.89 | 1,343,278,296.95 | 657,700,173.93 | 352,317,075.33 |
经营活动现金流入的平衡项目 | 0 | 0 | 0 | 0 |
经营活动现金流入小计 | 79,759,012,697.12 | 56,278,564,532.47 | 38,270,177,710.02 | 17,853,728,357.49 |
购买商品、接受劳务支付的现金 | 50,722,388,522.64 | 36,987,356,280.97 | 24,449,842,489.79 | 12,582,340,090.81 |
客户贷款及垫款净增加额 | 217,353,581.79 | 132,893,633.97 | -179,576,515.88 | 163,423,484.12 |
存放中央银行和同业款项净增加额 | - | 96,555,360 | 27,382,673.56 | 32,188,174.45 |
支付利息、手续费及佣金的现金 | 13,679,832.05 | 10,426,974.76 | 5,983,137.73 | 2,800,504.63 |
支付给职工以及为职工支付的现金 | 8,639,432,766.14 | 6,249,749,412.07 | 4,180,479,851.25 | 2,001,807,227.39 |
支付的各项税费 | 4,621,001,156.12 | 3,835,716,064.09 | 2,786,296,128.18 | 1,164,006,107.35 |
支付其他与经营活动有关的现金 | 2,514,605,789.3 | 1,529,158,955.97 | 853,294,959.2 | 534,244,065.16 |
经营活动现金流出的平衡项目 | 0 | 0 | 0 | 0 |
经营活动现金流出小计 | 66,728,461,648.04 | 48,841,856,681.83 | 32,123,702,723.83 | 16,480,809,653.91 |
经营活动产生的现金流量净额平衡项目 | 0 | 0 | 0 | 0 |
经营活动产生的现金流量净额 | 13,030,551,049.08 | 7,436,707,850.64 | 6,146,474,986.19 | 1,372,918,703.58 |
二、投资活动产生的现金流量: | ||||
收回投资收到的现金 | 12,594,200,306.21 | 172,276,436.62 | 172,555,671.24 | 200,656,219.17 |
取得投资收益收到的现金 | 91,414,865.5 | 95,283,755.77 | 28,577,996.23 | 11,396,581.44 |
处置固定资产、无形资产和其他长期资产收回的现金净额 | 310,858,386.52 | 91,487,377.1 | 91,096,287.1 | 3,982,433.74 |
处置子公司及其他营业单位收到的现金净额 | 7,459,605.66 | 8,118,180.76 | - | - |
收到的其他与投资活动有关的现金 | 5,625,284.2 | 3,303,309.02 | 2,773,542.38 | 1,187,012.36 |
投资活动现金流入的平衡项目 | 0 | 0 | 0 | 0 |
投资活动现金流入小计 | 13,009,558,448.09 | 370,469,059.27 | 295,003,496.95 | 217,222,246.71 |
购建固定资产、无形资产和其他长期资产支付的现金 | 8,003,682,542.72 | 3,916,289,649.43 | 2,616,063,371.75 | 1,655,842,451.35 |
投资支付的现金 | 13,603,175,300 | 1,311,665,131.15 | 569,836,465.56 | 260,827,936.52 |
投资活动现金流出的平衡项目 | 0 | 0 | 0 | 0 |
投资活动现金流出小计 | 21,606,857,842.72 | 5,227,954,780.58 | 3,185,899,837.31 | 1,916,670,387.87 |
投资活动产生的现金流量净额平衡项目 | 0 | 0 | 0 | 0 |
投资活动产生的现金流量净额 | -8,597,299,394.63 | -4,857,485,721.31 | -2,890,896,340.36 | -1,699,448,141.16 |
三、筹资活动产生的现金流量: | ||||
吸收投资收到的现金 | 289,804,178.46 | 232,930,900 | 224,950,900 | 61,100,900 |
其中:子公司吸收少数股东投资收到的现金 | 289,804,178.46 | - | - | - |
取得借款收到的现金 | 4,355,645,286.74 | 1,706,800,000 | 850,900,000 | 780,900,000 |
筹资活动现金流入平衡项目 | 0 | 0 | 0 | 0 |
筹资活动现金流入小计 | 4,645,449,465.2 | 1,939,730,900 | 1,075,850,900 | 842,000,900 |
偿还债务支付的现金 | 8,680,116,919.58 | 3,565,029,439.9 | 2,091,513,439.9 | 850,886,000 |
分配股利、利润或偿付利息支付的现金 | 3,289,269,586.65 | 3,101,048,717.57 | 2,952,257,657.02 | 204,337,548.74 |
其中:子公司支付给少数股东的股利、利润 | 113,772,727.11 | - | - | - |
支付其他与筹资活动有关的现金 | 277,721,235.5 | 2,360,019.83 | 1,591,373.11 | 500,000 |
筹资活动现金流出平衡项目 | 0 | 0 | 0 | 0 |
筹资活动现金流出小计 | 12,247,107,741.73 | 6,668,438,177.3 | 5,045,362,470.03 | 1,055,723,548.74 |
筹资活动产生的现金流量净额平衡项目 | 0 | 0 | 0 | 0 |
筹资活动产生的现金流量净额 | -7,601,658,276.53 | -4,728,707,277.3 | -3,969,511,570.03 | -213,722,648.74 |
四、汇率变动对现金及现金等价物的影响 | -762,551.3 | 9,495.46 | 8,368.45 | -7,888.56 |
现金及现金等价物净增加额平衡项目 | 0 | 0 | 0 | 0 |
五、现金及现金等价物净增加额 | -3,169,169,173.38 | -2,149,475,652.51 | -713,924,555.75 | -540,259,974.88 |
加:期初现金及现金等价物余额 | 7,654,114,139.89 | 7,654,114,139.89 | 7,654,114,139.89 | 7,654,114,139.89 |
期末现金及现金等价物余额平衡项目 | 0 | 0 | 0 | 0 |
期末现金及现金等价物余额 | 4,484,944,966.51 | 5,504,638,487.38 | 6,940,189,584.14 | 7,113,854,165.01 |
补充资料: | ||||
净利润 | 5,950,340,061.2 | - | 3,464,258,701.91 | - |
资产减值准备 | 228,652,276.77 | - | 140,538,252.48 | - |
固定资产和投资性房地产折旧 | 4,000,975,647.84 | - | 1,848,727,655.58 | - |
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧 | 4,000,975,647.84 | - | 1,848,727,655.58 | - |
无形资产摊销 | 294,257,675.2 | - | 121,607,810.82 | - |
长期待摊费用摊销 | 4,901,974.73 | - | 3,177,147.89 | - |
处置固定资产、无形资产和其他长期资产的损失 | -142,977,294.99 | - | -93,559,975.76 | - |
固定资产报废损失 | -36,340,698.49 | - | -24,493,305.57 | - |
公允价值变动损失 | -43,231,225.32 | - | -24,267,025.94 | - |
财务费用 | 776,184,234.18 | - | 366,023,007.68 | - |
投资损失 | -139,385,803.15 | - | -50,479,921.09 | - |
递延所得税 | -204,718,672.3 | - | -67,574,516.16 | - |
其中:递延所得税资产减少 | -179,606,057.21 | - | -17,422,280.18 | - |
递延所得税负债增加 | -25,112,615.09 | - | -50,152,235.98 | - |
存货的减少 | -326,925,723.57 | - | 124,612,504.93 | - |
经营性应收项目的减少 | -13,827,958,511.99 | - | -835,815,550.25 | - |
经营性应付项目的增加 | 16,321,490,564.1 | - | 974,168,086.07 | - |
其他 | - | - | 157,391,492.73 | - |
现金的期末余额 | 4,484,944,966.51 | - | 6,940,189,584.14 | - |
减:现金的期初余额 | 7,654,114,139.89 | - | 7,654,114,139.89 | - |
公告日期 | 2024-03-29 | 2023-10-28 | 2023-08-30 | 2023-04-28 |
审计意见(境内) | 标准无保留意见 |